Clinical Trial Update: Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating valproic acid-based two-agent oral regimens in patients with advanced solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Solid Tumors | Phase 1 | Status: COMPLETED